Morphosys.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
100% 
Page quality
56% 
Page structure
75% 
Link structure
78% 
Server
45% 
External factors
100% 
SEO Score
Response time
0.28 s
File size
50.00 kB
Words
555
Media files
11
Number of links
60 internal / 2 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
MorphoSys | A global biopharmaceutical company
The length of the page title is perfect. (446 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Learn about MorphoSys. A commercial-stage biopharmaceutical company that develops innovative medicines, aspiring to redefine how cancer is treated.
The length of the meta description is perfect. (941 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.morphosys.com/en/home
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en
Server location: United States of America
The following language is defined by HTML: en
Alternate/Hreflang Links
(Somewhat important)
The specified alternate links have no errors.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
descriptionLearn about MorphoSys. A commercial-stage biopharmaceutical company that develops innovative medicines, aspiring to redefine how cancer is treated.
GeneratorDrupal 10 (https://www.drupal.org)
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1, shrink-to-fit=no
langen
x-ua-compatibleie=edge
charsetutf-8

Test up to 1.000 webpages of morphosys.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Some words from the page title are not used within the pages content
Words from the H1 heading are not used in the page content.
There are 4 text duplicates on this page:
  • Duplicate 1: Are you a U.S. resident? This portion of the MorphoSys website is inte...
  • Duplicate 2: Are you a U.S. resident? This portion of the MorphoSys website is inte...
The average number of words per sentence of 7.75 words is low.
This page contains 555 words. That's ok.
35.7% of the text are stop words.
The page contains a listing, which indicates a good text layout.
9 paragraphs were found on this page.
No placeholders texts or images were found.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
A viewport "width=device-width, initial-scale=1, shrink-to-fit=no" is provided.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 11 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
/themes/morphosys/logo.svgHome
.../2023-03/home_stage_v2.jpg?itok=VTtkTGGbTwo women laugh together outsideTwo women laugh together outside
...3-03/home_stage_mobile.jpg?itok=jJGKjP6YTwo women laugh together outsideTwo women laugh together outside
.../2023-03/home_pipeline.jpg?itok=CSxne-u5Woman in a lab looks into a microscope
...3/home_pipeline_mobile.jpg?itok=zGANagG9Woman in a lab looks into a microscope
...ve Workspace MorphoSys.png?itok=4kgNKocEMorphoSys colleagues during a Leadership Training
...space Mobile MorphoSys.png?itok=bpbslS1TMorphoSys colleagues during a Leadership Training
...10/Website Icon People.png?itok=jw8T6qbYIcon of three people
...-10/Website Icon Woman.png?itok=WHDuSjYHIcon of a woman
...-10/Website Icon Earth.png?itok=GphhJcrVicon of the world
...10/Website Icon Winner.png?itok=9A4ZF5xtIcon of a winner

Page structure

H1 heading
(Critically important)
Our Mission: More life for people with cancer
The H1 heading is perfect.
Headings
(Important)
The structure of headings is missing one or more levels. Do not skip heading levels.
There are 27 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H1 Our Mission: More life for people with cancer
H2 Flyout
H2 Our Science
H2 Developing Innovative Therapies
H2 Latest News
H2 Our Team
H2 Fostering an Inclusive Workplace
H2 BY THE NUMBERS
H2 Events & Conferences
H2 Annual General Meeting 2024
H2 Publication of Half-Year Report 2024
H2 Footer-first-column
H2 Footer-second-column
H2 Footer-third-column
H2 Footer-fifth-column
H3 Science
H3 Company
H3 Careers
H3 Investors
H3 Media
H3 MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
H3 Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
H3 MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
H5 464
H5 60 %
H5 37
H5 41 %
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
There are 3 links with a trivial anchor text.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 2 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.morphosys.com/en/homeAnchor Skip to main content
https://www.morphosys.com/en/homeen
https://www.morphosys.com/de/homede
/en/investors/Novartis-Takeove...Subdomain Acquisition of MorphoSys by Novartis Closed. MorphoSys is now a Novartis Company.
https://www.morphosys.com/enIMG-ALT Home
A-TITLE Home
/en/scienceScience
/en/scienceLearn more
/en/our-pipelinePipeline
/en/our-pipeline/pelabresibPelabresib
/en/our-pipeline/tulmimetostatTulmimetostat
/en/our-pipeline/expanded-acce...Expanded Access Program
/en/about-usCompany
/en/about-usText duplicate Learn more
/en/leadershipLeadership
/en/about-us/responsibilityResponsibility
/en/about-us/our-historyHistory
/en/careersCareers
/en/careersText duplicate Learn more
/en/careers/job-openingsJob Openings
/en/investorsInvestors
/en/investorsText duplicate Learn more
/en/investors/Novartis-Takeove...Novartis Takeover Offer Information
/en/investors/financial-inform...Financial Information
/en/investors/corporate-govern...Corporate Governance
/en/investors/stock-informationStock Information
https://www.morphosys.com/en/agmAnnual General Meeting 2023
/en/annual-general-meetings-ar...Past Annual General Meeting Archive
/en/all-events-conferencesEvents & Conferences
/en/mediaMedia
/en/mediaText duplicate Learn more
/en/news/allPress Releases
https://www.morphosys.com/en/homeText duplicate en
https://www.morphosys.com/de/homeText duplicate de
/en/about-usText duplicate Learn more
/en/our-pipelineText duplicate Learn more
/en/news/morphosys-announces-v...MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
/en/news/morphosys-announces-v...Trivial anchor text
Read more
/en/news/ad-hoc-merger-squeeze...Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
/en/news/ad-hoc-merger-squeeze...Text duplicate Trivial anchor text
Read more
/en/news/morphosys-and-novarti...MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
/en/news/morphosys-and-novarti...Text duplicate Trivial anchor text
Read more
/en/news/allView all news
/en/careers/job-openingsjoin our team
/en/ics/25457Subdomain Save the date
/en/ics/24894Subdomain Text duplicate Save the date
/en/all-events-conferencesVIEW ALL EVENTS
/en/careersText duplicate Careers
/en/leadershipText duplicate Leadership
/en/our-pipelineText duplicate Pipeline
/en/about-us/responsibilityText duplicate Responsibility
/en/investorsText duplicate Investors
/en/mediaText duplicate Media
https://www.linkedin.com/compa...New window External Subdomain No Text
https://twitter.com/morphosysNew window External No Text
/en/imprintImprint
/en/terms-and-conditionsTerms and Conditions
/en/privacy-policyPrivacy Policy
/en/contact-usContact Us
https://www.morphosys.com/enSubdomain Cancel
https://www.morphosys.com/enSubdomain No
https://www.morphosys.com/enSubdomain Text duplicate No
https://www.morphosys.com/enSubdomain Text duplicate No

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.morphosys.com/en/home"
HTTP header
(Important)
The HTML page should be transferred using GZip compression.
No X-Powered HTTP header is sent.
Performance
(Somewhat important)
The page response time is excellent with 0.28 seconds.
The file size of the HTML document is fine (50 kB).

HTTP Response Header

NameValue
dateSun, 14 Jul 2024 06:54:22 GMT
content-typetext/html; charset=UTF-8
content-length51161
x-content-type-optionsnosniff
cache-controlmax-age=900, public
content-languageen
x-frame-optionsSAMEORIGIN
expiresSun, 19 Nov 1978 05:00:00 GMT
last-modifiedSat, 13 Jul 2024 19:11:13 GMT
etag"1720897873"
varyCookie
access-control-allow-origin*
strict-transport-securitymax-age=15724800
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 118 referring domains.
This page has 27,295 backlinks.
This page has backlinks from 107 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 0 shares and comments on Facebook.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.md
Disallow: /composer/Metapackage/README.txt
Disallow: /composer/Plugin/ProjectMessage/README.md
Disallow: /composer/Plugin/Scaffold/README.md
Disallow: /composer/Plugin/VendorHardening/README.txt
Disallow: /composer/Template/README.txt
Disallow: /modules/README.txt
Disallow: /sites/README.txt
Disallow: /themes/README.txt
Disallow: /web.config
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register
Disallow: /user/password
Disallow: /user/login
Disallow: /user/logout
Disallow: /media/oembed
Disallow: /*/media/oembed
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password
Disallow: /index.php/user/register
Disallow: /index.php/user/login
Disallow: /index.php/user/logout
Disallow: /index.php/media/oembed
Disallow: /index.php/*/media/oembed

Similar sites

Search preview

www.morphosys.com › home
MorphoSys | A global biopharmaceutical company
Learn about MorphoSys. A commercial-stage biopharmaceutical company that develops innovative medicines, aspiring to redefine how cancer is treated.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
MorphoSys75%Check
cancer62%Check
Company61%Check
people54%Check
Global50%Check
Innovative50%Check
Mission50%Check
life50%Check
Learn46%Check
redefine46%Check
Show more keywords and terms

Test up to 1.000 webpages of morphosys.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions